Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Irvin

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Journal of Clinical Pharmacology|September 1, 2023
Immunogenicity of Cemiplimab: Low Incidence of Antidrug Antibodies and Cut-Point Suitability Across Tumor TypesJenny L Valentine, Andrew Dengler, An Zhao, et al.
Bioanalysis|November 8, 2021
REGEN-COV<sup>®</sup> antibody cocktail bioanalytical strategy: comparison of LC-MRM-MS and immunoassay methods for drug quantificationSusan C Irvin, Samit Ganguly, Rachel Weiss, et al.
Analytical Chemistry|August 31, 2021
Liquid Chromatography-Multiple Reaction Monitoring-Mass Spectrometry Assay for Quantitative Measurement of Therapeutic Antibody Cocktail REGEN-COV Concentrations in COVID-19 Patient SerumXuefei Zhong, Shruti Nayak, Lili Guo, et al.
Frontiers in Immunology|March 26, 2026
The role of large immune complexes in anti-drug antibody development: a case study of anti-SARS-CoV-2 antibody therapeutics and co-administered mRNA vaccineSusan C Irvin, Zhiqiang Wang, Samit Ganguly, et al.
The AAPS Journal|December 11, 2024
Challenging the Standard Immunogenicity Assessment Approach: 1-Tiered ADA Testing Strategy in Clinical TrialsChing-Ha Lai, Mu Chen, Sasha Fraser, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2007
Coexpression of IL-5 and eotaxin-2 in mice creates an eosinophil-dependent model of respiratory inflammation with characteristics of severe asthmaSergei I Ochkur, Elizabeth A Jacobsen, Cheryl A Protheroe, et al.
Clinical Pharmacology and Therapeutics|December 14, 2023
Subcutaneous Administration of Monoclonal Antibodies: Pharmacology, Delivery, Immunogenicity, and Learnings From Applications to Clinical DevelopmentJohn D Davis, Marçal Bravo Padros, Daniela J Conrado, et al.
The AAPS Journal|October 23, 2025
Association of Immunogenicity and Drug Exposure and the Importance of Target Engagement in ADA Development: A Clinical Case Study of Anti-SARS-CoV-2 BiotherapeuticsSusan C Irvin, Samit Ganguly, Zhiqiang Wang, et al.
Molecules (Basel, Switzerland)|June 11, 2020
The Intriguing Effects of Substituents in the <i>N</i>-Phenethyl Moiety of Norhydromorphone: A Bifunctional Opioid from a Set of "Tail Wags Dog" ExperimentsMeining Wang, Thomas C Irvin, Christine A Herdman, et al.
BMJ Open|October 9, 2024
Assessing the safety and pharmacokinetics of casirivimab and imdevimab (CAS+IMD) in a cohort of pregnant outpatients with COVID-19: results from an adaptive, multicentre, randomised, double-blind, phase 1/2/3 studyThomas D Norton, Mazhar Thakur, Samit Ganguly, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Journal of Clinical Pharmacology|September 1, 2023
Immunogenicity of Cemiplimab: Low Incidence of Antidrug Antibodies and Cut-Point Suitability Across Tumor TypesJenny L Valentine, Andrew Dengler, An Zhao, et al.
Bioanalysis|November 8, 2021
REGEN-COV<sup>®</sup> antibody cocktail bioanalytical strategy: comparison of LC-MRM-MS and immunoassay methods for drug quantificationSusan C Irvin, Samit Ganguly, Rachel Weiss, et al.
Analytical Chemistry|August 31, 2021
Liquid Chromatography-Multiple Reaction Monitoring-Mass Spectrometry Assay for Quantitative Measurement of Therapeutic Antibody Cocktail REGEN-COV Concentrations in COVID-19 Patient SerumXuefei Zhong, Shruti Nayak, Lili Guo, et al.
Frontiers in Immunology|March 26, 2026
The role of large immune complexes in anti-drug antibody development: a case study of anti-SARS-CoV-2 antibody therapeutics and co-administered mRNA vaccineSusan C Irvin, Zhiqiang Wang, Samit Ganguly, et al.
The AAPS Journal|December 11, 2024
Challenging the Standard Immunogenicity Assessment Approach: 1-Tiered ADA Testing Strategy in Clinical TrialsChing-Ha Lai, Mu Chen, Sasha Fraser, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2007
Coexpression of IL-5 and eotaxin-2 in mice creates an eosinophil-dependent model of respiratory inflammation with characteristics of severe asthmaSergei I Ochkur, Elizabeth A Jacobsen, Cheryl A Protheroe, et al.
Clinical Pharmacology and Therapeutics|December 14, 2023
Subcutaneous Administration of Monoclonal Antibodies: Pharmacology, Delivery, Immunogenicity, and Learnings From Applications to Clinical DevelopmentJohn D Davis, Marçal Bravo Padros, Daniela J Conrado, et al.
The AAPS Journal|October 23, 2025
Association of Immunogenicity and Drug Exposure and the Importance of Target Engagement in ADA Development: A Clinical Case Study of Anti-SARS-CoV-2 BiotherapeuticsSusan C Irvin, Samit Ganguly, Zhiqiang Wang, et al.
Molecules (Basel, Switzerland)|June 11, 2020
The Intriguing Effects of Substituents in the <i>N</i>-Phenethyl Moiety of Norhydromorphone: A Bifunctional Opioid from a Set of "Tail Wags Dog" ExperimentsMeining Wang, Thomas C Irvin, Christine A Herdman, et al.
BMJ Open|October 9, 2024
Assessing the safety and pharmacokinetics of casirivimab and imdevimab (CAS+IMD) in a cohort of pregnant outpatients with COVID-19: results from an adaptive, multicentre, randomised, double-blind, phase 1/2/3 studyThomas D Norton, Mazhar Thakur, Samit Ganguly, et al.
Pageof 5